首页> Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology> The diffusion-weighted magnetic resonance imaging (DWI) predicts the early response of esophageal squamous cell carcinoma to concurrent chemoradiotherapy.

The diffusion-weighted magnetic resonance imaging (DWI) predicts the early response of esophageal squamous cell carcinoma to concurrent chemoradiotherapy.

导出原文传递

翻译打印收藏纠错

第一作者： Lan,Wang

第一单位： Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China. Electronic address: wlan2006@sina.com.

作者： Lan,Wang ^[1] ; Lihong,Liu ^[2] ; Chun,Han ^[3] ; Shutang,Liu ^[2] ; Hua,Tian ^[2] ; Zhensheng,Li ^[2] ; Xuejiao,Ren ^[2] ; Gaofeng,Shi ^[4] ; Qi,Wang ^[4] ; Guangda,Wang ^[4]

作者单位： Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China. Electronic address: wlan2006@sina.com. ^[1] Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China. ^[2] Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China. Electronic address: hanchun2006@126.com. ^[3] Department of Radiology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China. ^[4]

关键词 Apparent diffusion coefficient Diffusion-weighted magnetic resonance imaging Esophageal neoplasms Radiotherapy Therapeutic effect